We met with Dr Claudio Orlich (Cataract and Refractive Surgeon, Clinica 20/20 San José, Cosat Rica) at the 2018 WOC meeting to discuss the newly FDA-approved miLOOP™ (ianTECH, Reno, NV, UA) device. In this interview, Dr Orlich explains how the miLOOP device works to break down cataracts, and compares it to femtosecond laser. He also discusses the advantages and limitations of this device and offers his advice to cataract surgeons.
1. Could you tell us how the miLOOP™ technology works? (0:29)
2. What are the main advantages of the miLOOP device? (2:02)
3. What are the main limitations of the miLOOP device? (2:56)
4. Which patients are most likely to benefit from this technique? (3:29)
5. What advice would you offer to cataract surgeons to improve their proficiency with the technique? (4:11)
Filmed at the 2018 World Ophthalmology Congress (WOC) of the International Council of Ophthalmology (ICOPH), June 2018, Barcelona, Spain.
Share this Video
Related Videos In Cataract Surgery
Jorge L Alió, EGS 2020 – Innovations in Premium IOLs
We caught up with Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) to find out the most promising recent advances in premium IOLs. Questions Could you give us a brief overview of your experience with premium IOLs? (0:05) What are the most promising recent advances and what issues with premium IOLs remain to […]
Cynthia Matossian, AAO 2020 – Outcomes With Dexamethasone Intraocular Suspension 9% and Concomitant Postoperative Anti-inflammatory Medications
It was a huge pleasure to catch up with our esteemed Editorial Board member, Cynthia Matossian (Matossian Eye Associates, Hopewell and Hamilton, NJ, USA), as she talked us through her AAO presentation on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications. Questions What is the rationale for the use of dexamethasone intraocular […]
John A Hovanesian, AAO 2020 – The D3 Study
It was a pleasure to speak with our valued Editorial Board member, John A Hovanesian (Harvard Eye Associates, Laguna Hills, CA, USA), about his AAO 2020 poster presentation on the D3 study, evaluating dexamethasone intraocular suspension versus prednisolone acetate 1%. Questions What are the challenges of topical medications after cataract surgery? (00:06) Could you tell […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!